DK1915171T3 - Fremgangsmåde til bevarelse af funktionen af insulin-producerende celler - Google Patents

Fremgangsmåde til bevarelse af funktionen af insulin-producerende celler

Info

Publication number
DK1915171T3
DK1915171T3 DK06789148.1T DK06789148T DK1915171T3 DK 1915171 T3 DK1915171 T3 DK 1915171T3 DK 06789148 T DK06789148 T DK 06789148T DK 1915171 T3 DK1915171 T3 DK 1915171T3
Authority
DK
Denmark
Prior art keywords
insulin
producing cells
function
keeping
procedure
Prior art date
Application number
DK06789148.1T
Other languages
Danish (da)
English (en)
Inventor
Anders Hasager Boss
Wayman Wendell Cheatham
David C Diamond
Original Assignee
Mannkind Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mannkind Corp filed Critical Mannkind Corp
Application granted granted Critical
Publication of DK1915171T3 publication Critical patent/DK1915171T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK06789148.1T 2005-08-01 2006-08-01 Fremgangsmåde til bevarelse af funktionen af insulin-producerende celler DK1915171T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70429505P 2005-08-01 2005-08-01
PCT/US2006/030014 WO2007016600A2 (en) 2005-08-01 2006-08-01 Method of preserving the function of insulin-producing cells

Publications (1)

Publication Number Publication Date
DK1915171T3 true DK1915171T3 (da) 2013-12-09

Family

ID=37561086

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06789148.1T DK1915171T3 (da) 2005-08-01 2006-08-01 Fremgangsmåde til bevarelse af funktionen af insulin-producerende celler

Country Status (10)

Country Link
EP (1) EP1915171B1 (https=)
JP (2) JP2009503093A (https=)
CN (1) CN101232899A (https=)
AU (1) AU2006275424B2 (https=)
BR (1) BRPI0614489A2 (https=)
CA (1) CA2617226A1 (https=)
DK (1) DK1915171T3 (https=)
ES (1) ES2439455T3 (https=)
MX (1) MX2008001643A (https=)
WO (1) WO2007016600A2 (https=)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
US6923175B2 (en) 2002-03-20 2005-08-02 Mannkind Corporation Inhalation apparatus
ATE486064T1 (de) 2004-08-20 2010-11-15 Mannkind Corp Katalyse der diketopiperazinsynthese
KR20130066695A (ko) 2004-08-23 2013-06-20 맨카인드 코포레이션 약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염
MX373000B (es) 2005-09-14 2020-05-21 Mannkind Corp Metodo para formulacion de farmaco basado en el aumento de la afinidad de agentes activos hacia las superficies de microparticulas cristalinas.
EP1986679B1 (en) 2006-02-22 2017-10-25 MannKind Corporation A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
CN101827626B (zh) 2008-06-13 2015-03-18 曼金德公司 干粉吸入器和用于药物输送的系统
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
ES2421385T3 (es) 2008-06-20 2013-09-02 Mannkind Corp Aparato interactivo y procedimiento para establecer el perfil, en tiempo real, de esfuerzos de inhalación
TWI532497B (zh) 2008-08-11 2016-05-11 曼凱公司 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
DK2379100T3 (en) * 2009-01-08 2014-12-01 Mannkind Corp Treatment of hyperglycemia with GLP-1
CN102438602B (zh) * 2009-03-04 2016-04-13 曼金德公司 改进的干燥粉末药物输送系统
DK2405963T3 (da) 2009-03-11 2013-12-16 Mannkind Corp Apparat, system og fremgangsmåde til at måle modstand i en inhalator
KR102584844B1 (ko) 2009-06-12 2023-10-04 맨카인드 코포레이션 한정된 비표면적을 갖는 디케토피페라진 마이크로입자
CA2778698A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
CN102985125A (zh) 2010-06-21 2013-03-20 曼金德公司 干粉药物输送系统和方法
SG194034A1 (en) 2011-04-01 2013-11-29 Mannkind Corp Blister package for pharmaceutical cartridges
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
MX2014004983A (es) 2011-10-24 2014-09-22 Mannkid Corp Metodos y composiciones para tratar dolor.
KR102264177B1 (ko) 2012-07-12 2021-06-11 맨카인드 코포레이션 건조 분말 약물 전달 시스템 및 방법
US9171343B1 (en) 2012-09-11 2015-10-27 Aseko, Inc. Means and method for improved glycemic control for diabetic patients
US9897565B1 (en) 2012-09-11 2018-02-20 Aseko, Inc. System and method for optimizing insulin dosages for diabetic subjects
WO2014066856A1 (en) 2012-10-26 2014-05-01 Mannkind Corporation Inhalable influenza vaccine compositions and methods
EP3587404B1 (en) 2013-03-15 2022-07-13 MannKind Corporation Microcrystalline diketopiperazine compositions, methods for preparation and use thereof
MX375448B (es) 2013-07-18 2025-03-06 Mannkind Corp Composiciones farmacéuticas en polvo seco estables al calor y métodos.
EP3030294B1 (en) 2013-08-05 2020-10-07 MannKind Corporation Insufflation apparatus
US9486580B2 (en) 2014-01-31 2016-11-08 Aseko, Inc. Insulin management
US9898585B2 (en) 2014-01-31 2018-02-20 Aseko, Inc. Method and system for insulin management
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
EP3933845A3 (en) 2014-10-27 2022-06-22 Aseko, Inc. Subcutaneous outpatient management
US11081226B2 (en) 2014-10-27 2021-08-03 Aseko, Inc. Method and controller for administering recommended insulin dosages to a patient
JP7109155B2 (ja) 2015-06-04 2022-07-29 キッコーマン株式会社 フラビン結合型グルコースデヒドロゲナーゼを用いたグルコースの測定方法
EP3337402B1 (en) 2015-08-20 2026-01-07 Glytec, LLC Diabetes management therapy advisor
CN110187123B (zh) * 2019-05-06 2022-07-22 天津医科大学总医院 一种糖尿病早期诊断生物标志物及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1259045A (zh) * 1997-04-02 2000-07-05 普渡研究基金会 蛋白质的口服释放方法
ES2569916T3 (es) * 1999-06-29 2016-05-13 Mannkind Corporation Formulaciones farmacéuticas que comprenden insulina complejada con una dicetopiperazina
GB0217382D0 (en) * 2002-07-26 2002-09-04 Pfizer Ltd Process for making orally consumable dosage forms
WO2004080401A2 (en) * 2003-03-06 2004-09-23 Emisphere Technologies, Inc. Oral insulin therapies and protocol
ES2584867T3 (es) * 2004-01-12 2016-09-29 Mannkind Corporation Un método que reduce los niveles séricos de proinsulina en diabéticos de tipo 2

Also Published As

Publication number Publication date
JP2009503093A (ja) 2009-01-29
BRPI0614489A2 (pt) 2011-03-29
WO2007016600A3 (en) 2007-05-31
AU2006275424B2 (en) 2013-01-10
CA2617226A1 (en) 2007-02-08
CN101232899A (zh) 2008-07-30
EP1915171B1 (en) 2013-11-20
JP2015091854A (ja) 2015-05-14
EP1915171A2 (en) 2008-04-30
MX2008001643A (es) 2008-04-07
ES2439455T3 (es) 2014-01-23
AU2006275424A1 (en) 2007-02-08
WO2007016600A2 (en) 2007-02-08

Similar Documents

Publication Publication Date Title
DK1915171T3 (da) Fremgangsmåde til bevarelse af funktionen af insulin-producerende celler
MX2008006589A (es) Composiciones de edulcorante natural de mesa, de alta potencia, con perfil temporal y/o de sabor mejorado, metodos para su formulacion, y usos
ECSP099413A (es) COMPUESTOS A BASE DE 4 - fenil - 6 - (2,2,2 - trifluoro - 1 - feniletoxi)pirimidina Y MÉTODOS PARA SU EMPLEO
DK2321321T3 (da) Triazolo [4,5-d]pyramidinderivater og anvendelse deraf som purinreceptorantagonister
CR9365A (es) Compuestos y metodos para la inhibicion de la protein-cinasa raf
AR069474A1 (es) Material anticorrosivo
JP2007525551A5 (https=)
ECSP078013A (es) Inhibidores heterocíclicos de mek y métodos de uso de ellos
BRPI0514474A (pt) multiparticulados
CL2016002589A1 (es) Uso del compuesto genz-112638 (eliglustat), inhibidor de glucosilceramida sintasa, en el tratamiento de la enfermedad de gaucher y enfermedad de fabry (divisional de solicitud 201201348).
CR8642A (es) Compuestos, composiciones farmaceuticas y metodos para su uso en el tratameinto de desordenes metabolicos
CL2011000301A1 (es) Compuestos derivados de purina con actividad inmunomoduladora; composición farmacéutica que los comprende; y uso de ellos en el tratamiento de enfermedades alérgicas, rinitis alérgica, asma, enfermedades infecciosas y cáncer.
ECSP088692A (es) Compuestos basados en imidazol, composiciones que comprenden a los mismos y métodos de su uso
CL2010001483A1 (es) Compuestos derivados de 5-fenil-1h-piridin-2-ona y 6-fenil-2h-piridazin-3-ona, inhibidores de tirosina-quinasa (btk); composicion farmaceutica que comprende a dichos compuestos y su uso para el tratamiento de un estado patologico inflamatorio y/o autoinmune.
BRPI0516257A (pt) composição de gordura, método para a preparação de mesa, e, uso de uma composição de gordura
NZ595706A (en) L-ornithine phenyl acetate and methods of making thereof
GT200800065A (es) Métodos y composiciones para modular la hemostasia
WO2007095594A3 (en) Methods and compositions for enhancing engraftment of hematopoietic stem cells
AR053827A1 (es) Composiciones de tigeciclina y metodos de preparacion
PL2431430T3 (pl) Zastosowanie mikronizowanych kompozycji konserwujących drewno w nośnikach organicznych
BRPI0506839A (pt) composições e métodos para induzir a cardiomiogênese
ECSP099675A (es) Compuestos heterocíclicos, composición y métodos de uso
ECSP077997A (es) Moduladores de alquilquinolina y alquilquinazolina cinasa
ITTO20040390A1 (it) Composizione, in particolare per uso farmaceutico, ad azione antiossidante, antinfiammatoria ed immunostimolante.
NO20075368L (no) Antiinflammatoriske modaliteter